ABOUT BIOSENSE
Biosense is a medical technology company that has developed extremely sensitive nanomaterial-based biosensors that enable rapid measurement of important biofluids from a small sample of saliva. We are focused on the diabetes market, where saliva-based glucose measurement could dramatically improve monitoring of Type II diabetics who don't use blood-based glucometers. Biosense technology enables rapid monitoring of glucose without a fingerstick.
Biosense Business Strategy
• Biosense is a medical device company with wellness product spinoffs
• Wellness products will be driven by a strategic partner, who is one of the biggest distributors of test strips in U.S. drugstores
• Disease detection is a longer-term goal, with key technology developments by two partners in a Joint Venture, with the support of Biosense
Biosense-EMED Collaboration
• EMED Technologies Corporation has invested in Biosense, and is providing key resources:
- Facilities (see photo at right)
- Engineering, QA, Regulatory
- Working capital
• Collaboration with EMED enables efficient development with minimal budget
